Systemic antiphospholipid syndrome and atherosclerosis

Clinical Reviews in Allergy and Immunology

Volumn 32, Issue 2, 2007, Pages 172-177

  Jara, Luis J ^a,b   Medina, Gabriela ^a   Vera Lastra, Olga ^a,b  

^a HOSPITAL DE ESPECIALIDADES   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Antiphospholipid syndrome; Atherosclerosis; Immune inflammatory system

Indexed keywords

BETA2 GLYCOPROTEIN 1; CD40 ANTIGEN; CD40 LIGAND; CELL ADHESION MOLECULE; HEAT SHOCK PROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID ANTIBODY;

ADAPTIVE IMMUNITY; ANTIPHOSPHOLIPID SYNDROME; ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; BLOOD VESSEL DIAMETER; CAROTID ARTERY; CELL PROLIFERATION; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; DEEP VEIN THROMBOSIS; DENDRITIC CELL; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; HUMAN; INNATE IMMUNITY; MACROPHAGE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PREMENOPAUSE; PREVALENCE; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; SMOOTH MUSCLE FIBER; T LYMPHOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOPHILIA; VEIN THROMBOSIS;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; ATHEROSCLEROSIS; BETA 2-GLYCOPROTEIN I; FEMALE; HUMANS; INFLAMMATION; LIPOPROTEINS, LDL; MACROPHAGES; MALE; MYOCYTES, SMOOTH MUSCLE; OXIDATIVE STRESS; PREGNANCY; SEX FACTORS; T-LYMPHOCYTES;

EID: 35348883289     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12016-007-0008-9     Document Type: Review

References (54)

1. Ross R (1999) Atherosclerosis: an inflammatory disease. N Engl J Med 340:115-126
2. Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685-1695
3. Jara LJ, Medina G, Vera-Lastra O, Amigo MC (2006) Accelerated atherosclerosis, immune response and autoimmune rheumatic diseases. Autoimmun Rev 5:195-201
4. Shoenfeld Y, Gerli R, Doria A, Matsuura E, Cerinic MM, Ronda N et al (2005) Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 112:3337-3347
5. Sherer Y, Shoenfeld Y (2002) Atherosclerosis. Ann Rheum Dis 61:97-99
6. Vlachoyiannopoulos PG, Samarkos M (2004) Peripheral vascular disease in antiphospholipid syndrome. Thromb Res 114:509-519
7. Vaarala O (1996) Antiphospholipid antibodies and atherosclerosis. Lupus 5:442-447
8. Vaarala O, Puurunen M, Lukka M, Alfthan G, Leirisalo-Repo M, Aho K et al (1996) Affinity-purified cardiolipin-binding antibodies show heterogeneity in their binding to oxidized low-density lipoprotein. Clin Exp Immunol 104:269-274
9. Horkko S, Miller E, Dudl E, Reaven P, Curtiss LK, Zvaifler NJ et al (1996) Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. J Clin Invest 98:815-825
10. George J, Afek A, Gilburd B, Levy Y, Blank M, Kopolovic J et al (1997) Atherosclerosis in LDL-receptor knockout mice is accelerated by immunization with anticardiolipin antibodies. Lupus 6:723-729
11. Hasunuma Y, Matsuura E, Makita Z, Katahira T, Nishi S, Koike T (1997) Involvement of beta 2-glycoprotein I and anticardiolipin antibodies in oxidatively modified low-density lipoprotein uptake by macrophages. Clin Exp Immunol 107:569-573
12. George J, Haratz D, Shoenfeld Y (2001) Accelerated atheroma, antiphospholipid antibodies, and the antiphospholipid syndrome. Rheum Dis Clin North Am 27:603-610
13. George J, Shoenfeld Y, Harats D (1999) The involvement of beta2-glycoprotein I (beta2-GPI) in human and murine atherosclerosis. J Autoimmun 13:57-60
14. George J, Yacov N, Breitbart E, Bangio L, Shaish A, Gilburd B et al (2004) Suppression of early atherosclerosis in LDL-receptor deficient mice by oral tolerance with beta 2-glycoprotein I. Cardiovasc Res 62:603-609
15. Groyer E, Caligiuri G, Laschet-Khallou J, Nicoletti A (2006) Immunological aspects of atherosclerosis. Presse Med 35:475-486
16. George J, Harats D, Gilburd B, Afek A, Shaish A, Kopolovic J et al (2000) Adoptive transfer of beta(2)-glycoprotein I-reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice. Circulation 102:1822-1827
17. Blank M, Krause I, Lanir N, Vardi P, Gilburd B, Tincani A et al (1995) Transfer of experimental antiphospholipid syndrome by bone marrow cell transplantation. The importance of the T cell. Arthritis Rheum 38:115-122
18. Visvanathan S, McNeil HP (1999) Cellular immunity to beta 2-glycoprotein-1 in patients with the antiphospholipid syndrome. J Immunol 162:6919-6925
19. Hattori N, Kuwana M, Kaburaki J, Mimori T, Ikeda Y, Kawakami Y (2000) T cells that are autoreactive to beta2-glycoprotein I in patients with antiphospholipid syndrome and healthy individuals. Arthritis Rheum 43:65-75
20. Ito H, Matsushita S, Tokano Y, Nishimura H, Tanaka Y, Fujisao S et al (2000) Analysis of T cell responses to the beta 2-glycoprotein I-derived peptide library in patients with anti-beta 2-glycoprotein I antibody-associated autoimmunity. Hum Immunol 61:366-377
21. Karakantza M, Theodorou GL, Meimaris N, Mouzaki A, John E, Andonopoulos AP et al (2004) Type 1 and type 2 cytokine-producing CD4+ and CD8+ T cells in primary antiphospholipid syndrome. Ann Hematol 83:704-711
22. Arai T, Yoshida K, Kaburaki J, Inoko H, Ikeda Y, Kawakami Y et al (2001) Autoreactive CD4(+) T-cell clones to beta2-glycoprotein I in patients with antiphospholipid syndrome: preferential recognition of the major phospholipid-binding site. Blood 98:1889-1896
23. Kuwana M (2004) Beta2-glycoprotein I: antiphospholipid syndrome and T-cell reactivity. Thromb Res 114:347-355
24. Yoshida K, Arai T, Kaburaki J, Ikeda Y, Kawakami Y, Kuwana M (2002) Restricted T-cell receptor beta-chain usage by T cells autoreactive to beta(2)-glycoprotein I in patients with antiphospholipid syndrome. Blood 99:2499-2504
25. Fischer K, Collins H, Taniguchi M, Kaufmann SH, Schaible UE (2002) IL-4 and T cells are required for the generation of IgG1 isotype antibodies against cardiolipin. J Immunol 168:2689-2694
26. Ames PR, Tommasino C, Fossati G, Matsuura E, Margarita A, Saulino A et al (2005) Lymphocyte subpopulations and intima media thickness in primary antiphospholipid syndrome. Lupus 14:809-813
27. Shortell CK, Ouriel K, Green RM, Condemi JJ, DeWeese JA (1992) Vascular disease in the antiphospholipid syndrome: a comparison with the patient population with atherosclerosis. J Vasc Surg 15:158-165
28. Levy PJ, Cooper CF, Gonzalez MF (1995) Massive lower extremity arterial thrombosis and acute hepatic insufficiency in a young adult with premature atherosclerosis associated with hyperlipoprotein(a)emia and antiphospholipid syndrome. A case report. Angiology 46:853-858
29. Spronk PE, Overbosch EH, Scut NH (2001) Severe atherosclerotic changes including aortic occlusion , associated with hyperhomocysteinaemia and antiphospholipid antibodies. Ann Rheum Dis 60:699-701
30. Evans SM, Brittenden J, Adam DJ, Ludlam C, Bradbury AW (1999) Vascular surgical society of Great Britain and Ireland: prevalence and significance of thrombophilia in patients with intermittent claudication. Br J Surg 86:702-703
31. Rosove MH, Brewer PM (1992) Antiphospholipid thrombosis. Clinical course after the first thrombotic event in 70 patients. Annals Int Med 117:303-308
32. Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GR (1995) The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 332 (15):993-997
33. Gomez-Puerta JA, Martin H, Amigo MC, Aguirre MA, Camps MT, Cuadrado MJ et al (2005) Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus? Medicine (Baltimore) 84:225-230
34. Medina G, Vera-Lastra O, Angeles U, Jara LJ (2005) Monoorganic versus multi-organic involvement in primary antiphospholipid syndrome. Ann N Y Acad Sci 1051:304-312
35. Lopez LR, Dier KJ, Lopez D, Merrill JT, Fink CA (2004) Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome. Am J Clin Pathol 121:142-149
36. Lopez D, Kobayashi K, Merrill JT, Matsuura E, Lopez LR (2003) IgG autoantibodies against beta2-glycoprotein I complexed with a lipid ligand derived from oxidized low-density lipoprotein are associated with arterial thrombosis in antiphospholipid syndrome. Clin Dev Immunol 10:203-211
37. Ames PR, Delgado Alves J, Lopez LR, Gentile F, Margarita A, Pizzella L et al (2006) Antibodies against beta2-glycoprotein I complexed with an oxidised lipoprotein relate to intima thickening of carotid arteries in primary antiphospholipid syndrome. Clin Dev Immunol 13:1-9
38. Prandoni P, Bilora F, Marchiori A, Bernardi E, Petrobelli F, Lensing AW et al (2003) An association between atherosclerosis and venous thrombosis. N Engl J Med 348:1435-1441
39. Sueishi K, Ichikawa K, Kato K, Nakagawa K, Chen YX (1998) Atherosclerosis: coagulation and fibrinolysis. Semin Thromb Hemost 24:255-260
40. Sailer T, Vormittag R, Pabinger I, Vukovich T, Lehr S, Quehenberger P et al (2005) Inflammation in patients with lupus anticoagulant and implications for thrombosis. J Rheumatol 32:397-399
41. Wakefield TW, Henke PK (2005) The role of inflammation in early and late venous thrombosis: are there clinical implications? Semin Vasc Surg 18:118-129
42. Fox EA, Kahn SR (2005) The relationship between inflammation and venous thrombosis. A systematic review of clinical studies. Thromb Haemost 94:362-365
43. Vlachoyiannopoulus PG, Kanellopoulus PG, Ioannidis JP, Tektonidou MG, Mastorakou I, Moutsopoulos HM (2003) Atherosclerosis in premenopausal women with antiphospholipid syndrome and systemic lupus erythematosus: a controlled study. Rheumatology 42:645-651
44. Medina G, Casaos D, Jara LJ, Vera-Lastra O, Fuentes M, Barile L et al (2003) Increased carotid artery intima-media thickness may be associated with stroke in primary antiphospholipid syndrome. Ann Rheum Dis 62:607-610
45. Ames PR, Margarita A, Delgado Alves J, Tommasino C, Iannaccone L, Brancaccio V (2002) Anticardiolipin antibody titre and plasma homocysteine level independently predict intima media thickness of carotid arteries in subjects with idiopathic antiphospholipid antibodies. Lupus 11:208-214
46. Ames PRJ, Margarita A, Sokoll KB, Weston M, Brancaccio V (2005) Premature atherosclerosis in primary antiphospholipid syndrome: preliminary data. Ann Rheum Dis 64:315-317
47. Jara LJ, Medina G, Vera-Lastra O, Barile L (2005) The impact of gender on clinical manifestations of primary antiphospholipid syndrome. Lupus 14:607-612
48. Janardhan V, Wolf PA, Kase CS, Massaro JM, D'Agostino RB, Franzblau C et al (2004) Anticardiolipin antibodies and risk of ischemic stroke and transient ischemic attack: the Framingham cohort and offspring study. Stroke 35:736-741
49. Jimenez S, Garcia-Criado MA, Tassies D, Reverter JC, Cervera R, Gilabert MR et al (2005) Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome. Rheumatology (Oxford) 44:756-761
50. Baron MA, Khamashta MA, Hughes GR, D'Cruz DP (2005) Prevalence of an abnormal ankle-brachial index in patients with primary antiphospholipid syndrome: preliminary data. Ann Rheum Dis 64:144-146
51. Stalc M, Poredos P, Peternel P, Tomsic M, Sebestjen M, Kveder T (2006) Endothelial function is impaired in patients with primary antiphospholipid syndrome. Thromb Res 118(4):455-461
52. Vargas A, Ricalde A, Meave A, Vera-Lastra O, Vargas AR, Medina G et al (2004) Endothelial dysfunction in patients with primary antiphospholipid syndrome (APS) demonstrated with positron emission tomography. Arthritis Rheum 50(Suppl):S74
53. Espinola-Zavaleta N, Alexanderson-Rosas E, Granados N, Elena Soto M, Amigo MC (2006) Myocardial perfusion defects in patients with autoimmune diseases: a prospective study. Analysis of two diagnostic tests. Lupus 15:38-43
54. Medina-García G, Molina-Carrión LE, Angeles-Garay U, Vera-Lastra O, Jara-Quezada LJ (2006) Cerebral flow abnormalities in primary antiphospholipid syndrome patients demonstrated by transcranial doppler. A controlled study. J Rheumatol 33:424 (Abstract 73)